imp7068
impact therapeutics
['head and neck', 'wee1,(-wee1 inhibitor)', 'lung']
barbara burtness, md, and jong woo lee, phd, who presented research on combined aurka and wee1 inhibition as a novel and effective treatment for patients with head and neck or lung cancer with elevated aurka expression. #aacr23 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.